George Weiner

17PUBLICATIONS
59CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 01, 2026
Type 2 Deiodinase in Cancer-Associated Fibroblasts: A Potential Therapeutic Target in Many Types of Cancer.

|Aug 27, 2026
Correction: Veeramani et al. Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based Assay. Int. J. Mol. Sci. 2026, 27, 5469.

|Jun 26, 2026
Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based Assay.

|Apr 10, 2026
Intratumoral Virus-Like Particles Containing a TLR9 Agonist Combined with Systemic αPD-1 Activate Tumor-Specific CD8+ T Cells.

Travis D Fischer, Caitlin D Lemke-Miltner, George J Weiner

|Dec 17, 2024
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.

Islam Eljilany, Sam Coleman, Aik Choon Tan

|Mar 08, 2024
T-cell help in the tumor microenvironment enhances rituximab-mediated NK-cell ADCC.

Jyoti Arora, Sabarish Ayyappan, Chaobo Yin

Pageof 3

Frequent Collaborators

3 joint publications

Suresh Veeramani

3 joint publications

Brian J Smith

3 joint publications

Chaobo Yin

2 joint publications

Caitlin D Lemke-Miltner